Grove Inc. Completes Acquisition of VitaMedica, Making a Strong Entrance Into Nutraceuticals
Retrieved on:
Thursday, August 5, 2021
The closing of the acquisition will be immediately accretive to Grove, being both top line and net income positive for the company.
Key Points:
- The closing of the acquisition will be immediately accretive to Grove, being both top line and net income positive for the company.
- With this acquisition, the Company has taken direct aim at the vitamin + nutraceutical market in order to address the health + wellness needs of all consumers.
- VitaMedica stood out, not only because of its reputation and testimonials from consumers, but because of 25 years of clinical use and physician-formulated products.
- We at Grove are most excited about the team members we gained with the addition of Dr. Rahm, Yvette La-Garde and their entire team.